Enhancer of zeste homolog 2: A potential target for tumor therapy

被引：31
|
作者：
Xiao, Yongtao [1 ]
机构：
[1] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China
来源：
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY | 2011年 / 43卷 / 04期
关键词：
Enhancer of zeste homolog 2; H3K27; Methylation; Phosphorylation; Cancer therapy; GROUP PROTEIN EZH2; MALIGNANT MYELOID DISORDERS; H3; LYSINE-27; METHYLATION; PROSTATE-CANCER; HEPATOCELLULAR-CARCINOMA; CRITICAL REGION; GENE; EXPRESSION; MECHANISMS; BLADDER;
D O I：
10.1016/j.biocel.2011.01.005
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Enhancer of zeste homolog 2 (EZH2) is a subunit of the Polycomb-Repressive Complex 2 (PRC2), which catalyses the trimethylation of histone H3 on Lys 27 (H3K27) and involves in genes repression. EZH2 is amplified and overexpressed in a variety of cancers, including prostate and breast cancer. Overexpression of EZH2 has been associated with the invasion and progression of malignant cancers, especially with the progression of prostate cancer. Here, we review the structure and biological function of EZH2, especially focused on its activities in the tumorigenesis. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码：474 / 477
页数：4
相关论文
共 50 条
  • [1] Therapeutic potential of enhancer of zeste homolog 2 in autoimmune diseases
    Yang, Yue-Xin
    Shen, Hui-Hui
    Cao, Fan
    Xie, Liang-Yu
    Zhu, Guang-Lin
    Sam, Napoleon Bellua
    Wang, De-Guang
    Pan, Hai-Feng
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2019, 23 (12) : 1015 - 1030
  • [2] Potential of enhancer of zeste homolog 2 inhibitors for the treatment of SWI/SNF mutant cancers and tumor microenvironment modulation
    Pyziak, Karolina
    Sroka-Porada, Agnieszka
    Rzymski, Tomasz
    Dulak, Jozef
    Loboda, Agnieszka
    DRUG DEVELOPMENT RESEARCH, 2021, 82 (06) : 730 - 753
  • [3] Impact of Enhancer of Zeste Homolog 2 on T Helper
    Hou, Tsung-Yun
    Chen, Ming-Rong
    Chou, Yu-Ching
    Kan, Po-Chieh
    Tsai, Yi-Ta
    Cha, Tai-Lung
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [4] Functional roles of enhancer of zeste homolog 2 in gliomas
    Yin, Yatao
    Qiu, Shuwei
    Peng, Ying
    GENE, 2016, 576 (01) : 189 - 194
  • [5] Enhancer of zeste homolog 2 silencing inhibits tumor growth and lung metastasis in osteosarcoma
    Yang-Fan Lv
    Guang-Ning Yan
    Gang Meng
    Xi Zhang
    Qiao-Nan Guo
    Scientific Reports, 5
  • [6] Enhancer of zeste homolog 2 silencing inhibits tumor growth and lung metastasis in osteosarcoma
    Lv, Yang-Fan
    Yan, Guang-Ning
    Meng, Gang
    Zhang, Xi
    Guo, Qiao-Nan
    SCIENTIFIC REPORTS, 2015, 5
  • [7] Enhancer of zeste homolog 2 (EZH2) inhibitors
    Gulati, Nitya
    Beguelin, Wendy
    Giulino-Roth, Lisa
    LEUKEMIA & LYMPHOMA, 2018, 59 (07) : 1574 - 1585
  • [8] The enhancer of zeste homolog 2 (EZH2), a potential therapeutic target, is regulated by miR-101 in renal cancer cells
    Sakurai, Toshihiko
    Bilim, Vladimir N.
    Ugolkov, Andrey V.
    Yuuki, Kaori
    Tsukigi, Masaaki
    Motoyama, Teiichi
    Tomita, Yoshihiko
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 422 (04) : 607 - 614
  • [9] Enhancer of Zeste Homolog 2 in Colorectal Cancer Development and Progression
    Bremer, Sebastian C. B.
    Conradi, Lena-Christin
    Mechie, Nicolae-Catalin
    Amanzada, Ahmad
    Mavropoulou, Eirini
    Kitz, Julia
    Ghadimi, Michael
    Ellenrieder, Volker
    Stroebel, Philipp
    Hessmann, Elisabeth
    Gaedcke, Jochen
    Bohnenberger, Hanibal
    DIGESTION, 2021, 102 (02) : 227 - 235
  • [10] Application of enhancer of zeste homolog 2 immunocytochemistry to bile cytology
    Tone, Kiyoshi
    Ohno, Sachiyo
    Honda, Masatake
    Notsu, Akifumi
    Sasaki, Keiko
    Sugino, Takashi
    CANCER CYTOPATHOLOGY, 2021, 129 (08) : 612 - 621
12345